NTRA
NTRA
NASDAQ · Biotechnology

Natera Inc

$390.90
+20.26 (+5.47%)
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Buy 26 87%
Hold 4 13%
Sell 0 0%
Price Target
Analyst Price Target -63.4% upside
Low Target $88.14
Average Target $142.91
High Target $188.78
Current Price $390.90
Current
$390.90
Target
$142.91
$88.14 $142.91 avg $188.78
Scenario Analysis
Bear Case
$88.14
-77.5%
Low target
Base Case
$142.91
-63.4%
Avg target
Bull Case
$188.78
+-51.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$366.70
6.6% from high
52-Week Low
$157.43
+148.3% from low
50-Day SMA
$229.31
+70.5% vs SMA
200-Day SMA
$186.42
+109.7% vs SMA
RSI (14)
38.6
Neutral
Target vs 52W High
$142.91
-61.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%